Tumor vasculature is the first step for T cells to enter the neoplasm, so PD-L1 expressed on the first line of defense is the foremost factor in diminishing the anti-tumor function of T cells, which may indicate a poorer prognosis for patients. Here, CD274 is linked to neoplasm.